Tarsus Pharmaceuticals, Inc. - 10-Q Filing

Tarsus Pharmaceuticals reports Q3 2026 financial results including updates on Alkeus Pharmaceuticals and Renix Medical acquisitions.

SEC EDGAR ·

Tickers: $TARS

Read the full article at SEC EDGAR

More Regulatory news